West Pharmaceutical Services Aktie
332,67USD | 3,34USD | 1,01% |
WKN: 864330 / ISIN: US9553061055
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99,40 |
The Vanguard Group, Inc. | 12,43 |
Vanguard Group, Inc. (Subfiler) | 11,96 |
State Street Corp. | 4,44 |
Artisan Partners Holdings LP | 4,23 |
Walter Scott & Partners Ltd. | 3,81 |
AllianceBernstein LP | 3,59 |
BlackRock Fund Advisors | 3,44 |
APG Asset Management NV | 3,19 |
Vanguard Total Stock Market ETF | 3,17 |
Franklin Advisers, Inc. | 3,11 |
Brown Advisory LLC | 3,03 |
Stichting Pensioenfonds ABP (Global Equity Portfolio) | 2,95 |
Vanguard 500 Index Fund | 2,65 |
Geode Capital Management LLC | 2,40 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 8 200 | 9 200 | 10 065 | 10 700 | 10 600 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,22 | 0,23 | 0,28 | 0,27 | 0,28 |
Bilanz (in Mio. USD) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 1 059 | 1 374 | 1 742 | 1 920 | 1 936 |
Summe Anlagevermögen | 1 283 | 1 420 | 1 572 | 1 697 | 1 893 |
Summe Aktiva | 2 341 | 2 794 | 3 314 | 3 617 | 3 830 |
Bilanz (in Mio. USD) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 768 | 939 | 978 | 932 | 949 |
Summe Eigenkapital | 1 573 | 1 855 | 2 335 | 2 685 | 2 881 |
Summe Passiva | 2 341 | 2 794 | 3 314 | 3 617 | 3 830 |
Adresse
530 Herman O. West Drive, 19341-0645 Exton | |
Telefon | +1 (610) 594-2900 |
Fax | +1 (800) 345-9800 |
Internet | http://www.westpharma.com |
Management
Annette F. Favorite
Chief Human Resources Officer & Senior VP |
Bernard J. Birkett
Chief Financial Officer & Senior Vice President |
Chad R. Winters
Chief Accounting Officer, VP & Controller |
Chris Ryan
Senior Vice President-Containment & Glass Systems |
Cindy Reiss-Clark
Chief Commercial Officer & Senior Vice President |
Deborah L. V. Keller
Independent Director |
Donald A. McMillan
Vice President-Enterprise Business Systems |
Douglas A. Michels
Independent Director |
Eric Mark Green
Chairman, President & Chief Executive Officer |
Janet Brutschea Haugen
Director |
Kathy dePadua
Chief Quality Officer & Vice President |
Kimberly Banks MacKay
Secretary, General Counsel & Senior Vice President |
Mark A. Buthman
Independent Director |
Molly E. Joseph
Independent Director |
Myla P. Lai-Goldman
Independent Director |
Paolo Pucci
Lead Independent Director |
Quintin John Lai
Vice President-Strategy & Investor Relations |
Robert F. Friel
Independent Director |
Robert Segura
Vice President-Corporate Development |
Rudy Poussot
Senior VP-Strategy & Corporate Development |
Silji Abraham
Chief Technology Officer & Senior Vice President |
Stephen H. Lockhart
Independent Director |
Thomas W. Hofmann
Independent Director |
William F. Feehery
Independent Director |